- Telmisartan/hydrochlorothiazide
-
Telmisartan/hydrochlorothiazide Combination of Telmisartan Angiotensin II receptor antagonist Hydrochlorothiazide Thiazide diuretic Clinical data MedlinePlus a611031 Pregnancy cat. D(AU) D(US) Legal status ℞ Prescription only Routes Oral Identifiers ATC code C09DA07 PubChem CID 216293 KEGG D09219 (what is this?) (verify) Telmisartan/hydrochlorothiazide (INNs, trade name Micardis HCT) is an antihypertensive drug combination of an angiotensin II receptor antagonist with hydrochlorothiazide,[1] the commonest diuretic to be combined with other blood pressure lowering substances.
References
- ^ Drugs.com: Micardis HCT
Antihypertensives: agents acting on the renin-angiotensin system (C09) ACE inhibitors
("-pril")Sulfhydryl-containing: Captopril • Zofenopril
Dicarboxylate-containing: Enalapril# • Ramipril • Quinapril • Perindopril • Lisinopril (+HCT) • Benazepril
Phosphonate-containing: Fosinopril
Other/ungrouped: Alacepril • Cilazapril • Delapril • Imidapril • Moexipril • Rentiapril • Spirapril • Temocapril • TrandolaprilAIIRAs/
("-sartan")Azilsartan • Candesartan • Eprosartan • Irbesartan • Losartan • Olmesartan • Tasosartan§ • Telmisartan (+HCT) • Valsartan (+HCT)Renin inhibitors/
("-kiren")#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.